Tag Archives: NASDAQ:CYAD

H.C. Wainwright Maintains Their Buy Rating on Celyad (CYAD)

H.C. Wainwright analyst Edward White maintained a Buy rating on Celyad (CYAD – Research Report) today and set a price target of $37.00. The company’s shares closed last Monday at $7.25. According to TipRanks.com, White is a 5-star analyst with

JonesTrading Keeps a Buy Rating on Celyad (CYAD)

In a report released today, Soumit Roy from JonesTrading reiterated a Buy rating on Celyad (CYAD – Research Report). The company’s shares closed last Monday at $10.55, close to its 52-week low of $8.10. According to TipRanks.com, Roy is a

H.C. Wainwright Reiterates Their Buy Rating on Celyad (CYAD)

In a report released today, Edward White from H.C. Wainwright reiterated a Buy rating on Celyad (CYAD – Research Report), with a price target of $43.00. The company’s shares closed last Monday at $12.28. According to TipRanks.com, White is a

Celyad (CYAD) Receives a Buy from William Blair

William Blair analyst Raju Prasad maintained a Buy rating on Celyad (CYAD – Research Report) today. The company’s shares closed last Monday at $10.72, close to its 52-week low of $8.10. According to TipRanks.com, Prasad is a 5-star analyst with

JonesTrading Keeps Their Buy Rating on Celyad (CYAD)

In a report released today, Soumit Roy from JonesTrading reiterated a Buy rating on Celyad (CYAD – Research Report), with a price target of $60.00. The company’s shares closed last Monday at $8.88, close to its 52-week low of $8.10.

William Blair Sticks to Their Buy Rating for Celyad (CYAD)

William Blair analyst Raju Prasad maintained a Buy rating on Celyad (CYAD – Research Report) today. The company’s shares closed last Monday at $14.02. Prasad commented: “We view the enhanced product potency and persistence favorably and believe the proof-of-concept preliminary